Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Clinical trial NCT06024356 · COMPLETED
Trial details
- NCT number
- NCT06024356
- Sponsor
- Beijing Friendship Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-20
- Primary completion
- 2026-04-30
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.